MSB 0.00% 98.0¢ mesoblast limited

Ex Vivo Fucosylation of Third-Party Human Regulatory T Cells...

  1. 76 Posts.
    lightbulb Created with Sketch. 24
    Ex Vivo Fucosylation of Third-Party Human Regulatory T Cells Enhances Anti-Graft-Versus-Host Disease Potency in Vivo Adoptive therapy with regulatory T cells (Tregs) to prevent graft-versus-host disease (GVHD) would benefit from a strategy to improve homing to the sites of inflammation.

    ...... Just saying lol
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.000(0.00%)
Mkt cap ! $1.118B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1161 $1.02
 

Sellers (Offers)

Price($) Vol. No.
93.5¢ 16793 2
View Market Depth
Last trade - 09.48am 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.